[-] Show simple item record

dc.contributor.authorDanis, Peter G.eng
dc.date.issued2001-08eng
dc.description.abstractNo evidence was identified that provides a basis for determining whether EGD leads to improved outcomes in patients with GERD. However, patients with GERD referred for elective EGD who were found to have Barrett's esophagus were more likely to have symptoms for more than 1 year than patients who did not have Barrett's esophagus. Patients with esophageal adenocarcinoma were more likely to have frequent, severe, or longer duration of GERD symptoms. The calculated odds ratios (OR) for esophageal adenocarcinoma increased with increasing frequency, severity, or duration of GERD symptoms, independently or in combination.eng
dc.identifier.urihttp://hdl.handle.net/10355/2830eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2001 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectBarrett's esophaguseng
dc.subjectesophageal adenocarcinomaeng
dc.subjectchronic therapyeng
dc.subject.lcshAdenocarcinomaeng
dc.subject.lcshGastroesophageal refluxeng
dc.subject.lcshEsophagus -- Precancerous conditionseng
dc.subject.meshBarrett Esophaguseng
dc.titleWhich patients with gastroesophageal reflux disease (GERD) should have esophagogastroduoudenoscopy (EGD)?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record